Bristol-Myers Squibb
BMY
2,295 hedge funds and large institutions have $96.6B invested in Bristol-Myers Squibb in 2021 Q3 according to their latest regulatory filings, with 110 funds opening new positions, 977 increasing their positions, 879 reducing their positions, and 152 closing their positions.
20% more call options, than puts
Call options by funds: $1.57B | Put options by funds: $1.31B
11% more repeat investments, than reductions
Existing positions increased: 977 | Existing positions reduced: 879
1% more capital inflows, than outflows
Capital inflows: $4.47B | Capital outflows: $4.42B
0.3% more ownership
Funds ownership: 73.11% → 73.4% (+0.3%)
3% less funds holding
Funds holding: 2,371 → 2,295 (-76)
11% less funds holding in top 10
Funds holding in top 10: 72 → 64 (-8)
28% less first-time investments, than exits
New positions opened: 110 | Existing positions closed: 152
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Two Sigma Advisers
New York
|
+$381M |
| 2 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$314M |
| 3 |
Boston Partners
Boston,
Massachusetts
|
+$274M |
| 4 |
Barclays
London,
United Kingdom
|
+$154M |
| 5 |
JP Morgan Chase
New York
|
+$150M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$466M |
| 2 |
Viking Global Investors
Stamford,
Connecticut
|
-$283M |
| 3 |
Berkshire Hathaway
Omaha,
Nebraska
|
-$280M |
| 4 |
DZ Bank
Frankfurt Am Main,
Germany
|
-$203M |
| 5 |
American International Group
New York
|
-$149M |
BMY Hedge Fund Activity: Q3 2021 in Review
2,295 of the 5,732 institutional investors tracked by Wall St. Rank reported a position in Bristol-Myers Squibb (BMY) for Q3 2021, worth a combined $96.6B — down 11% from $109B a quarter earlier.
Sellers outnumbered buyers: 152 funds closed out of BMY and 110 opened new positions — a net loss of 42 holders — while 879 trimmed existing stakes and 977 added.
The largest buyer was Two Sigma Advisers, adding an estimated $381M. The largest seller was Fidelity Investments, cutting an estimated $466M.
- 2,295 institutional investors held Bristol-Myers Squibb (BMY) as of Q3 2021, down from 2,371 in Q2 2021.
- Funds reported $96.6B of Bristol-Myers Squibb stock for Q3 2021, down 11% quarter-over-quarter.
- 110 funds opened new Bristol-Myers Squibb positions in Q3 2021 and 152 closed out, a net change of -42 holders.
- The largest Bristol-Myers Squibb buyer in Q3 2021 was Two Sigma Advisers, an estimated $381M added.
- The largest Bristol-Myers Squibb seller in Q3 2021 was Fidelity Investments, an estimated $466M sold.
Based on aggregated 13F filings for Q3 2021.